TNF-α inhibits toll-like receptor 4 expression on monocytic cells via tristetraprolin during cardiopulmonary bypass

Shock

Volumn 32, Issue 1, 2009, Pages 40-48

  Tsai, Chien Sung ^a   Chen, Da Liang ^b,c   Lin, Sing Jong ^d   Tsai, Jui Chi ^a   Lin, Tso Chou ^a   Lin, Chih Yuan ^a   Chen, Yung Hsiang ^e   Huang, Go Shine ^a   Tsai, Hsiao Ya ^d   Lin, Feng Yen ^b,c   Li, Chi Yuan ^f,g  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

^f BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^g CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cardiopulmonary bypass; Toll like receptor; Tristetraprolin

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; DACTINOMYCIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TOLL LIKE RECEPTOR 4; TRISTETRAPROLIN; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MONOCYTE; OFF PUMP SURGERY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; RNA STABILITY; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

AGED; CARDIOPULMONARY BYPASS; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; IMMUNOPRECIPITATION; MIDDLE AGED; MONOCYTES; POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TOLL-LIKE RECEPTOR 4; TRISTETRAPROLIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67749093316     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318199608d     Document Type: Article

References (39)

1. Heumann D, Roger T: Initial responses to endotoxins and Gram-negative bacteria. Clin Chim Acta 323:59-72, 2002.
2. Zhang D, Zhang G, Hayden MS, Greenblatt MB, Bussey C, Flavell RA, Ghosh S: A toll-like receptor that prevents infection by uropathogenic bacteria. Science 303:1522-1526, 2004.
3. Aderem A, Ulevitch RJ: Toll-like receptors in the induction of the innate immune response. Nature 406:782-787, 2000.
4. Yang H, Young DW, Gusovsky F, Chow JC: Cellular events mediated by lipopolysaccharide-stimulated toll-like receptor 4. MD-2 is required for activation of mitogen-activated protein kinases and Elk-1. J Biol Chem 275:20861-20866, 2000.
5. Tsan MF, Clark RN, Goyert SM, White JE: Induction of TNF-alpha and MnSOD by endotoxin: role of membrane CD14 and toll-like receptor-4. Am J Physiol Cell Physiol 280:C1422-C1430, 2001.
6. Faure E, Thomas L, Xu H, Medvedev A, Equils O, Arditi M: Bacterial lipopolysaccharide and IFN-gamma induce toll-like receptor 2 and toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation. J Immunol 166:2018-2024, 2001.
7. Wolfs TG, Buurman WA, van Schadewijk A, de Vries B, Daemen MA, Hiemstra PS, van 't Veer C: In vivo expression of toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation. J Immunol 168:1286-1293, 2002.
8. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, Willeit J, Schwartz DA: Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347:185-192, 2002.
9. Ishida I, Kubo H, Suzuki S, Suzuki T, Akashi S, Inoue K, Maeda S, Kikuchi H, Sasaki H, Kondo T: Hypoxia diminishes toll-like receptor 4 expression through reactive oxygen species generated by mitochondria in endothelial cells. J Immunol 169:2069-2075, 2002.
10. Thobe BM, Frink M, Hildebrand F, Schwacha MG, Hubbard WJ, Choudhry MA, Chaudry IH: The role of MAPK in Kupffer cell toll-like receptor (TLR) 2-, TLR4-, and TLR9-mediated signaling following trauma-hemorrhage. J Cell Physiol 210:667-675, 2007.
11. Wen X, Wu GD: Evidence for epigenetic mechanisms that silence both basal and immune-stimulated transcription of the IL-8 gene. J Immunol 166: 7290-7299, 2001.
12. Kracht M, Saklatvala J: Transcriptional and post-transcriptional control of gene expression in inflammation. Cytokine 20:91-106, 2002.
13. Wang W, Caldwell MC, Lin S, Furneaux H, Gorospe M: HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation. EMBO J 19:2340-2350, 2000.
14. Wang W, Furneaux H, Cheng H, Caldwell MC, Hutter D, Liu Y, Holbrook N, Gorospe M: HuR regulates p21 mRNA stabilization by UV light. Mol Cell Biol 20:760-769, 2000.
15. Brewer G: An A + U-rich element RNA-binding factor regulates c-myc mRNA stability in vitro. Mol Cell Biol 11:2460-2466, 1991.
16. Xu N, Chen CY, Shyu AB: Versatile role for hnRNP D isoforms in the differential regulation of cytoplasmic mRNA turnover. Mol Cell Biol 21: 6960-6971, 2001.
17. Lai WS, Carballo E, Strum JR, Kennington EA, Phillips RS, Blackshear PJ: Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol Cell Biol 19:4311-4323, 1999.
18. Carballo E, Lai WS, Blackshear PJ: Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281:1001-1005, 1998.
19. Ming XF, Stoecklin G, Lu M, Looser R, Moroni C: Parallel and independent regulation of interleukin-3 mRNA turnover by phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase. Mol Cell Biol 21:5778-5789, 2001.
20. Sbrana S, Parri MS, De Filippis R, Gianetti J, Clerico A: Monitoring of monocyte functional state after extracorporeal circulation: a flow cytometry study. Cytometry B Clin Cytom 58:17-24, 2004.
21. Hadley JS, Wang JE, Michaels LC, Dempsey CM, Foster SJ, Thiemermann C, Hinds CJ: Alterations in inflammatory capacity and TLR expression on monocytes and neutrophils after cardiopulmonary bypass. Shock 27:466-473, 2007.
22. McBride WT, Armstrong MA, Crockard AD, McMurray TJ, Rea JM: Cytokine balance and immunosuppressive changes at cardiac surgery: contrasting response between patients and isolated CPB circuits. Br J Anaesth 75: 724-733, 1995.
23. Sbrana S, Bevilacqua S, Buffa M, Spiller D, Parri MS, Gianetti J, De Filippis R, Clerico A: Post-reperfusion changes of monocyte function in coronary blood after extracorporeal circulation. Cytometry B Clin Cytom 65:14-21, 2005.
24. Reynolds N, Collier B, Maratou K, Bingham V, Speed RM, Taggart M, Semple CA, Gray NK, Cooke HJ: Dazl binds in vivo to specific transcripts and can regulate the pre-meiotic translation of Mvh in germ cells. Hum Mol Genet 14:3899-3909, 2005.
25. Zeger SL, Liang KY: Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121-130, 1986.
26. Lin FY, Chen YH, Tasi JS, Chen JW, Yang TL, Wang HJ, Li CY, Chen YL, Lin SJ: Endotoxin induces toll-like receptor 4 expression in vascular smooth muscle cells via NADPH oxidase activation and mitogen-activated protein kinase signaling pathways. Arterioscler Thromb Vasc Biol 26:2630-2637, 2006.
27. Lin FY, Chen YH, Lin YW, Tsai JS, Chen JW, Wang HJ, Chen YL, Li CY, Lin SJ: The role of human antigen R, an RNA-binding protein, in mediating the stabilization of toll-like receptor 4 mRNA induced by endotoxin: a novel mechanism involved in vascular inflammation. Arterioscler Thromb Vasc Biol 26:2622-2629, 2006.
28. Mahtani KR, Brook M, Dean JL, Sully G, Saklatvala J, Clark AR: Mitogenactivated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol Cell Biol 21:6461-6469, 2001.
29. Borgermann J, Scheubel RJ, Simm A, Silber RE, Friedrich I: Inflammatory response in on- versus off-pump myocardial revascularization: is ECC really the culprit? Thorac Cardiovasc Surg 55:473-480, 2007.
30. Markewitz A, Lante W, Franke A, Marohl K, Kuhlmann WD, Weinhold C: Alterations of cell-mediated immunity following cardiac operations: clinical implications and open questions. Shock 16(suppl 1):10-15, 2001.
31. Borgermann J, Friedrich I, Flohe S, Spillner J, Majetschak M, Kuss O, Sablotzki A, Feldt T, Reidemeister JC, Schade FU: Tumor necrosis factoralpha production in whole blood after cardiopulmonary bypass: downregulation caused by circulating cytokine-inhibitory activities. J Thorac Cardiovasc Surg 124:608-617, 2002.
32. Struber M, Cremer JT, Gohrbandt B, Hagl C, Jankowski M, Volker B, Ruckoldt H, Martin M, Haverich A: Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass. Ann Thorac Surg 68:1330-1335, 1999.
33. Cavarocchi NC, England MD, Schaff HV, Russo P, Orszulak TA, Schnell WA Jr, O'Brien JF, Pluth JR: Oxygen free radical generation during cardiopulmonary bypass: correlation with complement activation. Circulation 74: III130-III133, 1986.
34. Volk HD, Reinke P, Docke WD: Clinical aspects: from systemic inflammation to "immunoparalysis." Chem Immunol 74:162-177, 2000.
35. Schulze C, Conrad N, Schutz A, Egi K, Reichenspurner H, Reichart B, Wildhirt SM: Reduced expression of systemic proinflammatory cytokines after off-pump versus conventional coronary artery bypass grafting. Thorac Cardiovasc Surg 48:364-369, 2000.
36. Diegeler A, Doll N, Rauch T, Haberer D, Walther T, Falk V, Gummert J, Autschbach R, Mohr FW: Humoral immune response during coronary artery bypass grafting: a comparison of limited approach, "off-pump" technique, and conventional cardiopulmonary bypass. Circulation 102:III95-III100, 2000.
37. Lei Y, Zhen J, Ming XL, Jian HK: Induction of higher expression of IL-beta and TNF-alpha, lower expression of IL-10 and cyclic guanosine monophosphate by pulmonary arterial hypertension following cardiopulmonary bypass. Asian J Surg 25:203-208, 2002.
38. Jalonen U, Lahti A, Korhonen R, Kankaanranta H, Moilanen E: Inhibition of tristetraprolin expression by dexamethasone in activated macrophages. Biochem Pharmacol 69:733-740, 2005.
39. Carballo E, Cao H, Lai WS, Kennington EA, Campbell D, Blackshear PJ: Decreased sensitivity of tristetraprolin-deficient cells to p38 inhibitors suggests the involvement of tristetraprolin in the p38 signaling pathway. J Biol Chem 276:42580-42587, 2001.